In this Thought Leader article., Ian Johnston from Cytiva discusses challenges related to process development, scaling technology, regulatory approvals, and GMP guidelines.

Most people don't enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such ...

Nanoparticles have once again reached the spotlight, this time as a critical tool to combat the spread of covid-19. In this ...

Lipid Nanoparticles (LNPs) are somewhat like liposomes, but more specifically developed to encapsulate various oligonucleotides (RNA and DNA), see Fig. 1c. They are currently the most popular non ...

Function-engineerable nanoparticles in combination with the advantageous effects of various functional lipid components enable achievement of enhanced blood stability, decreased toxicity and ...

This is your definitive industry-led meeting to discover new lipid-based nanoparticle formulations and engineer delivery systems for emerging payloads beyond RNA for extrahepatic delivery.

A new framework bridges a gap in understanding RNA therapeutics by linking the structure of lipid nanoparticles to immune ...

Penn Engineers have discovered a novel means of directing lipid nanoparticles (LNPs), the revolutionary molecules that ...

The recent success of the mRNA-LNP vaccines fueled biopharma to explore lipid-based nanoparticles for advanced drug delivery. The industry is now poised to exploit the full therapeutic potential ...

This is far more straightforward than the discussion of graphics settings, as changing the resolution tends to have a relatively linear impact on performance, and it's very easy to understand.

“As part of ElevateBio’s broad collection of cutting-edge technologies spanning cell, RNA, and gene editing, this platform reinforces our mission to offer comprehensive solutions to innovators ...